Fluorescent diagnostic probes in neurodegenerative diseases

J Zhou, P Jangili, S Son, MS Ji, M Won… - Advanced …, 2020 - Wiley Online Library
Neurodegenerative diseases are debilitating disorders that feature progressive and
selective loss of function or structure of anatomically or physiologically associated neuronal …

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?

F Bassil, PO Fernagut, E Bezard, WG Meissner - Progress in neurobiology, 2014 - Elsevier
Abstract Insulin and Insulin Growth Factor-1 (IGF-1) play a major role in body homeostasis
and glucose regulation. They also have paracrine/autocrine functions in the brain. The …

Electromagnetic fields, oxidative stress, and neurodegeneration

C Consales, C Merla, C Marino… - International journal of …, 2012 - Wiley Online Library
Electromagnetic fields (EMFs) originating both from both natural and manmade sources
permeate our environment. As people are continuously exposed to EMFs in everyday life, it …

The blood–cerebrospinal fluid barrier: structure and functional significance

CE Johanson, EG Stopa, PN McMillan - The Blood-Brain and Other …, 2011 - Springer
The choroid plexus (CP) of the blood–CSF barrier (BCSFB) displays fundamentally different
properties than blood-brain barrier (BBB). With brisk blood flow (10× brain) and highly …

Transthyretin: a multifaceted protein

M Vieira, MJ Saraiva - Biomolecular concepts, 2014 - degruyter.com
Transthyretin is a highly conserved homotetrameric protein, mainly synthetized by the liver
and the choroid plexus of brain. The carrier role of TTR is well-known; however, many other …

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

RJ Perrin, R Craig-Schapiro, JP Malone, AR Shah… - PloS one, 2011 - journals.plos.org
Background Ideally, disease modifying therapies for Alzheimer disease (AD) will be applied
during the 'preclinical'stage (pathology present with cognition intact) before severe neuronal …

Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro

X Li, X Zhang, ARA Ladiwala, D Du… - Journal of …, 2013 - Soc Neuroscience
Tissue-specific overexpression of the human systemic amyloid precursor transthyretin (TTR)
ameliorates Alzheimer's disease (AD) phenotypes in APP23 mice. TTR–β-amyloid (Aβ) …

Liraglutide and its Neuroprotective properties—focus on possible biochemical mechanisms in Alzheimer's disease and cerebral ischemic events

M Wiciński, M Socha, B Malinowski… - International journal of …, 2019 - mdpi.com
Liraglutide is a GLP-1 analog (glucagon like peptide-1) used primarily in the treatment of
diabetes mellitus type 2 (DM2) and obesity. The literature starts to suggest that liraglutide …

Extracellular protein homeostasis in neurodegenerative diseases

MR Wilson, S Satapathy, M Vendruscolo - Nature Reviews Neurology, 2023 - nature.com
The protein homeostasis (proteostasis) system encompasses the cellular processes that
regulate protein synthesis, folding, concentration, trafficking and degradation. In the case of …

Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative …

AI Duarte, E Candeias, IN Alves, D Mena… - International journal of …, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia worldwide, being
characterized by the deposition of senile plaques, neurofibrillary tangles (enriched in the …